Beyond Blood Sugar: How Science Tackles Obesity and Diabetes

2026-02-11
Beyond Blood Sugar: How Science Tackles Obesity and Diabetes

Video

Beyond Blood Sugar: How Science Tackles Obesity and Diabetes

Audio

Beyond Blood Sugar: How Science Tackles Obesity and Diabetes

Dr. Erich Schramm and Dr. Michael Koren deliver a presentation on diabetes and obesity to a live audience. The doctors discuss the role of willpower, how ultra-processed food hijacks our brains, and what a healthy diet looks like. They also discuss the myriad signaling molecules in the body that tell us we're hungry or full and when to digest all that food. The doctors also touch on the growing line of medications that are being used to control diabetes and obesity, and how the two diseases feed off of each other, which makes breaking the cycle difficult. The doctors discuss the surprising role a desert lizard plays in current weight-loss medications and offer a sneak preview of other investigational medications on the horizon.

 

Transcripts

Beyond Blood Sugar: How Science Tackles Obesity and Diabetes

Transcript generated by AI.

 

Announcement: 0:00

Welcome to the MedEvidence Podcast. This episode is a rebroadcast from a live MedEvidence presentation.

Dr. Michael Koren: 0:06

Moving on with our slide presentation, as you know, that this is not a passive event. This actually requires active engagement with the audience. And so you might think you're getting a free lunch, but in fact you're not. You're working for it. Okay. So we're going to start with this concept of it's the big it's January, it's the beginning of the year, right? We may or may not have made New Year's resolutions. So just to do a survey to get a sense for what's happening in the room. Who in the room, by show of hands, made a New Year's resolution to eat better, move more, or finally get healthy? Okay, so we'll do it one by one. There's going to be choices here. So number one, yes, I made a resolution this year. Raise your hand if that's true. Okay? That half? B, yes, I copied and pasted my resolution from last year to the new calendar. A show of hands? Yep. Okay. Okay. Three, I already forgot my new year's resolution. What was it? Number four, oops, I broke my New Year's resolution on January 2nd. Or okay, those are the choices. So I get a pretty good sense that these New Year's resolutions have the best intent, but they don't always happen. And Erich and I are going to talk a lot about the fact that you need two things to work together in order to fulfill our New Year's resolution and more broadly to live healthy lives. And this is a combination of willpower and Sally Science. Willpower and Sally Science both think they can cure the obesity diabetes conundrum on their own. And do you agree? So that's a rhetorical question, and we'll see if we can get to the answer to that. So go ahead, Erich. Just you know, give us a little bit of sense why one versus the other isn't necessarily the best equation in terms of success.

Dr. Erich Schramm: 2:01

Exactly. So as the slide says, if willpower alone worked, you know, we wouldn't need this presentation. You know, instead, diabetes and obesity are complex biological problems. Science is finally catching up. And a lot of times people facing that dilemma between donut and broccoli. So, you know, if science alone was enough, then we would have a singular treatment. Here's a pill, you're all set, without ever having to tackle anything other, other challenges, and we'd we'd all be easy and one and done, but obviously that's not the case. Okay, so what makes it so difficult to achieve our New Year's resolutions on weight loss and healthy eating? It really comes down, we can talk a little bit now about or talk about adipocytes and obesity. Now, fat cells. A lot of people think, well, your fatty tissues are just sitting there, kind of a annoying reservoir of potential energy, energy storage, and that it really doesn't really do much anything other than makes our waistline bigger and our and our and our hips bigger. But adipocytes, they're they're active. They're our fat cells are actually it's an endocrine and creates and promotes, secretes hormones, and and it's very important. And part of that is that they release free fatty acids into the circulation. Now, free fatty acids can turn into triglycerides, they can stimulate an inflammatory process, and they can cause and interfere with anti-inflammatory effects. So they're they're very potentially a concern for our health.

Dr. Michael Koren: 3:46

Yeah, and that's that's a great point, Eric. And just to emphasize the point, when you're overweight, your your adipocytes, these are cells that particularly have this biological function of making sure we eat enough and to store energy, go off into a rogue state. So we need these things because you know, back when there was lit- very little food around, we needed a constant reminder to eat and make sure we had enough energy in our bodies. But now these cells are actually overacting for the current environment, the current societal conditions. And so, really, when we have to deal with willpower, quote unquote, we're actually working against the natural mechanisms in our body that make us want to eat. So it's a really important point.

Dr. Erich Schramm: 4:34

All right. We talked about activite adipocytes, activate immune cells, further fueling inflammation and tissue remodeling. I think we've got some more slides so we can talk in a little more detail about them. So the dual role of adipose tissue in disease, um, we talked about already how they can be an initiate or trigger. So the fat cells are used, adipokines and other ways that they can stimulate inflammation. Inflammation is kind of a generic term that implies that you may be activating different parts of your immune system. So inflammatory responses that can cause at the as kind of the net processes, really a lot of endothelial dysfunction and damage, fibrosis, and atherosclerosis, because that's what the inside of your arteries are experiencing this. And so the many inflammatory cytokines, tumor necrosis factor, IL-1, IL-6, these are all part of these active what your your fatty tissues are doing. And so we look at some of the treatments we look like, and some of the new treatments we're looking at are looking at some of dealing with some of these inflammatory or inflammosomes. So if you can treat this, then you're not going to be so much into the exacerbator, which worsens and accelerates existing health conditions. So you really want to be more proactive up front, try to nip it in the bud, per se, before you set up that kind of chronic inflammation inflammation leading to endothelial cell dysfunction. So, you know, we want to treat it more upstream.

Dr. Michael Koren: 6:15

Yeah. And this gets a little bit nerdy, but this concept of cytokines is actually very, very important. So when you think about it, why do things that happen in our gut either make us feel full or hungry, Okay? Full and hungry comes from the brain, not from the gut. Well, the reason it is is because of all the signaling. And so the science is now focused on all these signaling things, whether it's appetite or inflammation or other things as Dr. Schram mentioned. So it's a little bit nerdy, but we put it in so you realize what scientists are thinking about in terms of what they're attacking, what they're trying to change.

Dr. Erich Schramm: 6:49

Question, why do we eat too much? We've already talked about, okay, well, the brain and the and the gut and your fat tissues and your internal organs should be communicating together to say, okay, when we're overfed or when our sugar is too high or we have too much excess, that we should be having the necessary kind of brakes to put onto the system and say, okay, let's eat less. Okay, let's let's you know, let's change what we're doing. But a lot of times people kind of we kind of override a lot of those signals. Now, this was an important study that came out this summer. It was, it was Duke University. And what what it looked at is, okay, well, what's contributing to obesity most? Is it that we're are we eating too many calories or are we just not exercising enough? Because a lot of people's strategy is like, well, I'm gonna watch my diet, but I'm just really gonna work out now. I'm gonna really work off this. I'm gonna I'm gonna lose weight through through exercise. And they looked around, it was global, it was a global study, and it looked at turns out that you know our calorie intake is much more a driver of obesity than our level of exercise. Now, I'm not saying don't exercise, but at the end of the day, it really does mean we really have to focus on what we eat, what we eat and and how we're eating. And when they looked at this study, and one of the big factors in this wasn't just that that people are eating more, but of the kind of food that really promotes a lot of the obesity, diabetes, heart disease, the inflammatory pro uh components in our diet, which is ultra-processed food. So they in here in the United States, 60% of our diet is ultra-processed foods. It's twice than any other country in the world. And so, you know, our obesity problem isn't just that we're eating too much, we're generally getting the wrong kind of calories, the wrong kind of nutrition in the diet from ultra-processed foods. So that was the take-home point from that.

Dr. Michael Koren: 8:56

So this gets into the concept of food noise, this whole gut-brain connection. So just before I get into the the choices, who has heard of food noise before in the room? So just relatively few. So those this will be interesting. So this is actually a term we're using scientifically now. And we're actually using this term in our clinical research to see if we can, quote, shut off food noise. So let's get into the question here. One uh food noise is persistent and intrusive thoughts about food. Would that be yes or no? B, a concept not limited to individuals with current eating disorders. Okay. C, an idea to describe as food-related intrusive thoughts. FRIT, always a good acronym, right?

Dr. Erich Schramm: 9:46

Sounds like you're splitting it.

Dr. Michael Koren: 9:47

It's not scientific unless you have a good acronym. That's we that's one of our rules. Is a contribution to overeating and obesity? So would you choose one of those, or would you go with E, all the above?

Dr. Erich Schramm: 10:01

Okay. There are paid attention. This is a smart audience.

Dr. Michael Koren: 10:06

I told you.

Dr. Erich Schramm: 10:06

Right. Okay. Okay.

Dr. Michael Koren: 10:08

So we got a super smart audience here. All the above is correct. So go ahead, break it down a little bit more for us.

Dr. Erich Schramm: 10:14

Okay. So food noise, the constant thinking about food, again, especially highly palatable and energy-dense foods, which for a lot of people, guess what? Ultra-processed foods. That's basically what they are. So frequently checking uh food delivery apps and obsessively planning the next meal during current meals. Okay. So if you find yourself that's never happened to me. Anyways, okay. Provoked by external food cues, seeing or smelling palatable foods or internal food cues, stomach rallying thoughts about food, often often intrusive. Now, I've been watching a lot of uh, you know, playoff football and college basketball and this kind of thing. And you notice how much food is being advertised in that, you know, a lot of fast food, ultra-processed foods. And you know, I can't imagine you're watching this, and people, of course, are getting hungry. So we've got a lot of we get a lot of cues, a lot of reinforcement out there. So so it's it is a real thing. So you're you're not the only person out there with that. And patients using weight loss medications report a significant reduction in food noise. And we're gonna talk a little more about weight loss medications in just a few minutes, but that is true. One of the things that we see for for some of these classes of weight loss medications is helps to silence that food noise. Patients are like, you know, I don't really feel like I have you know that kind of hearing and responding and needing to do all these things. So it can be really helpful.

Dr. Michael Koren: 11:43

Are you finished with this slide? Yes. Okay, sorry. I got a little- I got a little off track because I was thinking about dessert.

Dr. Erich Schramm: 11:51

Exactly. Well, you know, we got donuts and okay. Uh okay. That's a great slide. So so what okay, so this fat mouse. Okay, interesting. So eating, again, cookies and ultra-processed foods and all that, but interesting is down in the corner is a banana peel. And I was like, oh, okay, well, this mouse was onto something. So, but something derailed uh this mouse before, you know, he made the the right choice to go and eat uh fruits and vegetables rather than going for uh anyways. So hormones and appetite. So leptin is a satiety hormone and ghrelin is a hunger hormone, leptin and ghrelin. Now I will tell you there are other satiety hormones that are important. We'll talk about GLP-1. We'll talk about GIP. We'll talk about all of that too. But there are there are hormones that are secreted certain times of the day or evening that either drive our hunger up or down. And leptin is one I like to talk about. And people with leptin resistance tend to, it's it's it's our full signal, right? It's our satiety signal. And part of that can be mitigated in the diet if by fiber. Fiber, fiber is an important component in the way that that it stimulates satiety, and including leptin, it also stimulates GLP-1 release, which we'll talk about in just a little bit. So again, that's why diet uh very fiber is important. Obesity is protean. And basically, and I've heard Dr. Koren use this term uh a number of times, so I never get tired of seeing this slide. So it's a Greek, which means somebody, a god who could change the shape at will. And so it has in in clinical practices, it just means a diverse spectrum of clinical, metabolic, psychological, and functional presentations and complications, including cardiovascular, which are obviously the most some of the most significant. So it's it isn't just that it causes one thing and cause a whole variety of disease states.

Dr. Michael Koren: 14:01

Yeah. And this is really important what we're doing in clinical research, and we hope to get people interested in what we're doing in clinical research. So, for example, as we speak, we're doing studies right now looking at overweight patients with congestive heart failure. And how we can help congestive heart failure by in part treating obesity. We're looking at studies of diabetes and obesity, and how you can fix diabetes or make it less likely to cause complications based on treating obesity. We're doing these studies in arthritis. We're doing these studies, believe it or not, in compulsive behaviors because there's a connection between being overweight and having compulsive behaviors. So this is what we mean by protean. It interacts and causes all these manifestations, and sometimes we're trying to help the manifestations by treating this underlying cause. All right. Well, diabesity, that's a new word on me. Go ahead and explain that.

Dr. Erich Schramm: 14:56

Yeah, well, we've diabesity, right, because we're talking about obesity, but also diabetes. And so we've come over the years up with terms diabesity, and it just happens that a lot of the current weight loss medications evolved out of diabetic treatment. So this is, you know, so this is how we got comfortable starting to use that term. But it's it isn't just that having high sugar if you're a diabet a diabetic is necessarily the singular problem. It's the other things that go along with it insulin resistance, adiposity, you know, fat, inflammation, and hormonal dysregulation. And as Dr. Koren alluded to, you can see there's kind of a long list of things: cardiovascular disease, stroke, kidney disease, MASH is fatty liver disease, and it's kind of all the different things that can affect vision and peripheral and autonomic neuropathy, uh, and increase cancer risk, which is also a concern.

Dr. Michael Koren: 15:52

Yeah. And this is what we mean by the protean manifestations of obesity. So I'd recommend that you all use the word protean today with your friends, and they'll think you're really, really smart.

Dr. Erich Schramm: 16:03

That's right. Okay. So back, and we've already talked a little bit about complications and impact of diabesity. We often characterize them as either microvascular or macrovascular. So microvascular involves related to when when people have high sugar and like diabetes, it's it becomes really, it's a toxin. It becomes toxic to the nerves and it stimulates stimulates a lot of inflammation in the blood vessels and the in the smaller blood vessels, and then ends up with you get endothelial dysfunction, ischemia, and so you end up seeing, again, diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy. So all these things. And if you're a diabetic, you should be following up with your eye doctor and seeing your primary care doctor or your specialist. Macrovascular, this is what we think about in terms of cardiovascular, like if you've had coronary artery disease or peripheral vascular disease or stroke, and it's it's just it's an accelerated atherosclerosis driven by that insulin resistance, compounded if you have high blood pressure, cholesterol issues, or other kind of chronic inflammation. So that's how we look at it in the medical world. Oh, the choices to make, right? Not all calories are created equal, right? And so, no, right, I would say not all calories are created equal. Not all carbohydrates are created equal, by the way. But so the impact of 300 calories of say eating something that's healthier versus more kind of healthier protein or or your fiber versus something that's again ultra-processed, like a donut, which again leaves you hungry, you know, the an hour after you eat. So the the when we talk about you know nutrition with patients in the office, it isn't calorie counting so much. It's really getting down into the nuts and bolts, the nitty-gritty of what they're eating. What are you eating and what does that look like? And and but this is a good slide so people can take a good take-home message.

Dr. Michael Koren: 18:09

Yeah, there's is an interesting part of human conditioning that goes into this. So if you look at this slide and your eyes go down to the donut and think that's what you want to be doing, then we have some conditioning work to do. Whereas if you look at the salmon and say, oh wow, that looked amazing. I can't wait to do the salmon, then we've done our job. So that's part of what we're trying to accomplish here.

Dr. Erich Schramm: 18:33

Ah, food order impact on blood sugar. Okay. So, you know, you can we're gonna have a graph or two if it's gonna be, you know, an event here. So you'll know the top line, the yellow line is a when you eat your carbohydrate first, and then the bottom blue line to that is when you eat your carbohydrate last. So there was a necessary um food order impact on blood sugar. And so it's kind of interesting. So this was a showed that after consuming a protein or fiber first in the healthy part of it, that you could see a significant reduction in what it did for blood sugar compared to just eating your carbohydrate up front. So you know, the food order can have as uh significant impact on it.

Dr. Michael Koren: 19:19

Yeah, fascinating. Yeah.

Dr. Erich Schramm: 19:22

Okay. Tips. Okay. So,

Dr. Michael Koren: 19:28

everybody needs tips.

Dr. Erich Schramm: 19:29

Water is good. Drink half your body weight in in in ounces a day. So okay, you can do some math on that. Though I do tell patients I said, look, you know, but don't that's during the day. Don't consume half your body weight and fluid two hours before bedtime, or else you're gonna be up to pee a lot. Don't do that because you're you need to you need to sleep all night. So thinking about how you're eating, suggesting that eating perhaps your your protein and healthy fiber up front before the carbohydrates to reduce blood sugar spikes. But again, the the devil with the details about carbohydrate metabolism is you should, you know, we could talk a little bit about healthy carbs versus not so healthy carbs, but trying to choose good healthy carbohydrate sources, I think also is important. And then again, be aware of ultra-processed food that can provoke hormonal and metabolic changes that increase hunger and stress hormone levels. And that's true for all of those. I mean, you just cannot go there, you know. It's really a lot of times people, when they're doing or they're trying to really work on their diet, that sometimes they like to sneak in, oh, these little sneaky treats and everything. And it's tough because you continue to condition your body into that hormonal response. And you really, really need to try to stop, try to avoid doing that kind of eating.

Dr. Michael Koren: 20:50

So I know, Erich, you have some some pointed points to make or pointed opinions, is probably the best word, about the new food pyramid. So I'm gonna give you the clicker for this because I'm the clicker. And and give you the power there, and I'll let you go through, quote, the new food pyramid. I can just go through all this. Okay. And again, the the the goal here is the government wanted us to know what to eat more of and what to eat less of. That's ultimately what this is all about. But you why don't you walk people through this?

Dr. Erich Schramm: 21:22

Okay. So I when I saw this coming out again, I was it was a kind of a deja vu moment because I remember as a med student and a new resident, that's what this is a few decades ago. I was like, oh, that's like what the old food pyramid looked like. And for a long time, physicians and physician groups really did a deep dive into looking at that to say, okay, well, is that really understanding what we know about the science? Or was it that, you know, the government was being influenced by, you know, the industries and that put their, you know, put the that shaped that. So I guess we're kind of back to looking at and understanding you know this and why some of that is why that is some things that may be good about that but things I'd be be mindful about and so what the the premise of the reshaping of the of the the the food pyramid is it's it's put you know these kind of protein I'm just kind of putting here these kind of protein dense you know protein dense foods up front but not all the protein dense foods are created equal here so you can sort out you know these are this is kind of red meat versus here's an avocado which is a plant-based protein but and you're gonna say well why would one potentially be better say necessarily over the other and the answer is there's no there's no animal based protein that has any fiber you won't find fiber in any any animal based protein but for plant-based proteins it's a little bit different the legumes the avocados these things they have nuts etc they have both they have you know plant based fiber and protein so uh so if you can choose and they're less calorie dense than eating a steak so I try to encourage patients to consider they don't have to go vegetarian but at least consider a plant-centric diet right so using plant centric diet but we know that red meat certainly increases your risk for colon cancer I think that's been pretty well established and the World Health Organization came out in 2015 that said that processed meat products are carcinogenic class one so I think they treated that like smoking so that says a lot about the potential downside and dangers for consuming a lot of red meat and processed meats salmon you know people say well what about the the healthier uh protein options like salmon probably a better choice okay so and sometimes people say what about poultry and I say well depends poultry is probably a little bit um less problematic; animal-based foods have in them their constituent is choline or phosphatidylcholine which is lecithin. Lecithin actually stimulates the inflammatory process that lead to activation of macrophages formation of foam cells which if you've got coronary disease you hear your cardiologist talk about foam cells these macrophages that contain LDLs they're very athrogenic so you can so it's another kind of good reason to think about maybe moving into the meaning more into the the plant-based realm but you know whole grains again these may fall into the good carbohydrates you know versus bad carbohydrates how do you know what's a good carbohydrate and I'm like well you would prefer your carbohydrates instead of a white starches you want to look for starches with color like sweet potato whole grain breads you know so there are there are there are good choices to be made in this but I'm not eager to steer people in the realm dairy also falls into the types of food that's high in choline and so let's uh tell people try to generally try to stay away from that as much as they can

Dr. Michael Koren: 25:20

Thank you

Dr. Erich Schramm: 25:22

your your turn to drive that yeah

Dr. Michael Koren: 25:23

That's okay that those are great insights um you alluded to the fact that there may have been corporate influences in the food pyramid in the in the past-

Dr. Erich Schramm: 25:33

Can you imagine that?! right.

Dr. Michael Koren: 25:33

Yeah and and again I I don't know this for a fact but I found it interesting that this soup can looks a lot like a Campbell soup can. That's right. Is that right? That's right and and that there's all kinds of ways you can get soup right doesn't always have to look like that. That's number one. Interestingly that um milk is there which is looks like typical cow's milk rather than almond milk or something else right?

Dr. Erich Schramm: 25:58

Whole milk.

Dr. Michael Koren: 25:59

They want whole milk right and then and and then and sometimes people get locked out. So here you can see a fried egg and I know that the scrambled egg people are really upset about that.

Dr. Erich Schramm: 26:11

All right go ahead. Okay. So prevention and risk reduction. So this uh if you're diabetic or pre-diabetic of course you want to have good control of your A1C check make sure your blood pressure these are really managing your any kind of chronic intrinsic you have so optimize your blood pressure optimize your cholesterol don't smoke. So this is important to lower your long-term risk for both microvascular and macrovascular disease and think about early screening so you know if you've if you're diabetic you should be getting a an eye exam you should be seeing your primary care doctor regularly to monitor your kidney functions and consider the optimal medications to manage your condition ACE inhibitors are good to help to preserve uh my maintain good blood pressure and then the medications are out there that the SGLT2 inhibitors GLP1s these are which we're gonna talk a little bit about in the medication section here but they're excellent to consider helping to delay or progression of diabetes and they a lot of benefits now that we see in the GLP-1 range. So be be proactive be forward and proactive.

Dr. Michael Koren: 27:22

All right we have another audience response question all the below are medically accepted methods to lose weight except: calorie restrictive diets B bariatric surgery such as partial gastric bypass C medications such as approved classes like opioid antidepressant combo, fat blockers and GLP-1s the Ronco binge eating cleansing diet of popcorn colonics and moonshine or intensive physical activity program with standard meals. So D? Yeah I'm gonna go with all except D, and that is correct these guys are good, did I tell you

Dr. Erich Schramm: 28:04

I tell you they've they've been around a couple times.

Dr. Michael Koren: 28:08

Okay and here's another interesting little question a little bit of a trivia question what unlikely creature helped kickstart the development of GLP-1 therapies? Was it a hibernating bear that ignores winter weight gain advice? Is it B a bottom feeding fish from the Brazilian Amazon? Is it C camels that are famous for surviving long journeys without snacks? Is it D a desert lizard whose saliva helps keep blood sugar stable during long fast or is it E a Harvard medical student during a late night lab experiment? So who I'm just kind of curious in this one A, anybody say A? Any B? Anybody C's anybody D? Or anybody E? Okay well D is the correct answer so again really really smart audience.

Dr. Erich Schramm: 29:04

They've paid attention

Dr. Michael Koren: 29:07

Alright, so why don't you explain that to people, that's probably gotten them fascinated.

Dr. Erich Schramm: 29:09

Yeah so we're talking about the Gila not the "geela" but the Gila monster largest native venomous lizard in the U.S. And after long periods of not eating the Gila monster can maintain constant blood sugar levels. Hmm so a breakthrough discovery found a hormone in its saliva exendin-4 is similar to GLP-1 so what a what a what an origin story this is great. So looking for nature things that are out there in nature that you know we can incorporate in modern medicine.

Dr. Michael Koren: 29:42

Yeah so has anybody taken the drug Byetta or heard about it? Well this was the first one that we worked with the research we actually started those studies over 20 years ago and when we did those studies they were mostly for the treatment of diabetes and then this led to all the discoveries about GLP-1s and now they cure everything GLP-1. So it's amazing in 20 years you went from people saying are you crazy Dr. Koren you're gonna actually put me in a study where I get saliva from a ghilla monster that that's how it started and now we you know people are banging down my doors to get these prescriptions. Yeah so it's quite a transition. Okay. So how do GLP-1s work?

Dr. Erich Schramm: 30:26

Okay so glucagon-like peptide one receptor agonists so GLP-1 and as I mentioned it's it's hormonal and so it mimics gut hormones that reduce appetites slows your digestion and promote weight loss and they improve your metabolic health to reduce your risk of major heart heart related events and risk of death overall so we've been doing a lot of these studies but what its mechanism does so it increases insulin release. Remember these were initially antidiabetic medicines. So insulin release which is good because that helps to control your blood sugar and it decreases your liver's sugar glucose production and that makes sense if you're a diabetic because you're want you're you don't want that. It slows gastric emptying and improves satiety. So satiety you're full feeling

Dr. Michael Koren: 31:12

then this leads into the use of GLP-1s which we've we've actually worked with all these in our clinical research at our clinical research center and over the years we've proven a bunch of things about them. So the use of GLP-1 drugs such as Ozempic and Mounjaro has led to the following in research programs. Is it A the side effect of weight loss? Is it B the side effect of reduced disease and blood pressure? Is it C the side effect of improved skin conditions? Is it D the side effect of reduced compulsive behavior in preliminary studies? Or is it E all the above quote protean manifestations? There we go.

Dr. Erich Schramm: 31:52

Man they have earned their lunch today

Dr. Michael Koren: 31:54

unbelievable yeah but it's so interesting as as Dr. Schramm pointed out is that a lot of these things were studied for diabetes and we learned about all this other stuff because it was an unanticipated side effect which happened to be a good side effect. So so interesting let's talk about the next revolution

Dr. Erich Schramm: 32:13

Cool all right so combining different mechanisms of action to obtain more efficacious therapeutic treatment options. So so yeah GLP-1 has been around you know for two decades. I remember it was 10 years ago we did the probably one of the first semaglotide studies where we knew we could start to give this monthly and so but since then we've been able to recognize some of the other important hormones that are involved glucose dependent insulinotrophic polypeptide holy cow that's a lot we call it GIP. So GIP kind of like GLP but not exactly the same but it does boost the release of insulin and improves insulin sensitivity some reduction in nausea and vomiting but also is for like burning and metabolizing fat lipolysis is very good for that. We talked about GLP-1s enhancing insulin release slowing that gastric emptying right so your stomach you feel fuller sooner suppressing appetite and increasing satiety glucagon when you combine it with a GLP-1 it helps to facilitate some of the insulino tropic options and it actually can help lipolysis and the process and how your body metabolizes fat. So it's it's very helpful Amylin is also it's earlier used as an anti diabetic treatment we recognize in slowing gastric empty, promotes sciety, inhibits glucagon secretion it's interesting but it's also amylin is very good for that food noise. So people people in studies were we're combining GLP with amylin and they were doing that versus GLP versus GIP a lot of the people are reporting they get less of that food noise. So it's it's uh and amylin is very good in the long term for burning fat. So because when you burn fat you want okay you want your body to release the fat it has it's important that you burn it or metabolize it or otherwise it just goes back and gets stored as fat again. And so you know if you're combining medications that help the kind of get that process along so that you're eating less, you're taking less calories in and you're stimulating a process to to mobilize your fat, then this is when you see things really start to work for people. So so diet is important of course so we are best when Will and Sally work together lifestyles work best when it works with hormones not against them. We know obesity is biologically defended right because Dr. Koren said when we were our primitive selves we were our two biggest challenges were starvation and infection. So we develop a super hyperintense metabolic system to try to maintain our calories and a super amazing immune system that not is always these days working in our favor, but that's just the way it is and then to remind patients that chronic disease is not a personal failure and this touches base touches base to patients who come into the clinic and if you're trying to you've tried to lose weight but you just you know oh man I I couldn't do it you know January 2nd I was back in the fridge you know looking for something the don't take that as a kind of personal failure. We don't want that to to encourage that for patients.

Announcement: 35:36

Thanks for joining the MedEvidence podcast to learn more head over to medevidence.com or subscribe to our podcast on your favorite podcast platform